SNDX
Syndax Pharmaceuticals
$20.52
−$0.29 (−1.39%)Jul 27, 2026
Key metrics
The numbers that frame SNDX today
- Market cap
- $1.82B
- P/E (TTM)
- -7.5
- EV / FCF
- -7.3
- Gross margin
- 96%
- EV / Sales
- 9.3
- ROIC
- -31.6%
- Div yield
- 0%
- Debt / equity
- 8.3
- 52wk Low
- $9.42
- 52wk High
- $25.59
Growth
Revenue and earnings trend for SNDX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SNDX
Is Syndax Pharmaceuticals a good buy?
Yes. Syndax Pharmaceuticals has excellent momentum, and it outweighs the weak quality here. Growth looks excellent, which supports the long-term business case. We think Syndax Pharmaceuticals is selling at a very high price, which cuts against the buy case.
What is the market capitalization of SNDX?
Syndax Pharmaceuticals's market capitalization is $1.82B.
What is the P/E ratio for SNDX stock?
Syndax Pharmaceuticals's current P/E ratio is -7.5.
What is the 52-week high for SNDX stock?
The 52-week high for Syndax Pharmaceuticals is $25.59. The current close of $20.52 is 19.8% below that high.
What is the 52-week low for SNDX stock?
The 52-week low for Syndax Pharmaceuticals is $9.42. The current close of $20.52 is 117.8% above that low.
Does SNDX stock pay dividends?
Syndax Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SNDX?
Syndax Pharmaceuticals's Debt / Equity ratio is 8.3.